Sio Capital Management, LLC — 13F Holdings & Portfolio
CIK 1482416 · latest 13F-HR filed 2026-08-14
Sio Capital Management, LLC manages $604.3M in 13F-reported U.S. long-equity assets across 59 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are AVR (9.04%), COR (8.13%), MMS (6.36%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 15 new positions and exited 31; 14 existing positions rose in reported value and 23 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 50.1%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 18, 2026.
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| CASTOR, MICHAEL, BERNARD Control | MANAGING MEMBER since Mar 2006 | 75% or more | Individual |
| DRILLICK, JUDAH, ZVI Control | CHIEF EXECUTIVE OFFICER since Jul 2015 | Less than 5% | Individual |
| LEE, JIN, WOO Control | CHIEF COMPLIANCE OFFICER since Feb 2021 | Less than 5% | Individual |
Ownership & leadership changes · 7 filings with changes since Apr 26, 2013
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedVIGNEAU, ALBERT, CHARLES · PARTNER · Less than 5% · control person · listed since Mar 2011
- AddedLEE, JIN, WOO · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- ChangedDRILLICK, JUDAH, ZVI · title CHIEF EXECUTIVE OFFICER AND CHIEF COMPLIANCE OFFICER → CHIEF EXECUTIVE OFFICER
- ChangedDRILLICK, JUDAH, ZVI · title CHIEF COMPLIANCE OFFICER AND CHIEF FINANCIAL OFFICER → CHIEF EXECUTIVE OFFICER AND CHIEF COMPLIANCE OFFICER
- ChangedDRILLICK, JUDAH, ZVI · title CHIEF COMPLIANCE OFFICER → CHIEF COMPLIANCE OFFICER AND CHIEF FINANCIAL OFFICER
- ChangedVIGNEAU, ALBERT, CHARLES · title CHIEF FINANCIAL OFFICER → PARTNER
- AddedDRILLICK, JUDAH, ZVI · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- ChangedVIGNEAU, ALBERT, CHARLES · title CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER → CHIEF FINANCIAL OFFICER
- ChangedCASTOR, MICHAEL, BERNARD · title MANAGING MEMBER OF THE ADVISER AND THE GP → MANAGING MEMBER
- ChangedVIGNEAU, ALBERT, CHARLES · title CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER OF THE ADVISER AND THE GP → CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER
- ChangedCASTOR, MICHAEL, BERNARD · title MANAGING MEMBER → MANAGING MEMBER OF THE ADVISER AND THE GP
- ChangedVIGNEAU, ALBERT, CHARLES · title CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER → CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER OF THE ADVISER AND THE GP
- ListedCASTOR, MICHAEL, BERNARD · MANAGING MEMBER · 75% or more · control person
- ListedVIGNEAU, ALBERT, CHARLES · CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER · Less than 5% · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- ANTERIS TECHNOLOGIES GLOBAL$24.8M +82.9%
- CENCORA INC$17.4M +55.0%
- ORUKA THERAPEUTICS INC$10.4M +159.4%
- SENSEONICS HLDGS INC$8.3M +1073.2%
- ZIMMER BIOMET HOLDINGS INC$5.7M +99.9%
Top Trims
- DIANTHUS THERAPEUTICS INC-$25.3M -81.4%
- WAYSTAR HLDG CORP-$20.6M -52.0%
- ICON PUB LTD CO-$18.6M -54.8%
- ANI PHARMACEUTICALS INC-$12.4M -60.6%
- MAXIMUS INC-$10.8M -22.0%
New Positions
- ALLOGENE THERAPEUTICS INC$27.7M
- GLOBUS MED INC$23.8M
- IDEAYA BIOSCIENCES INC$17.9M
- THE CIGNA GROUP$15.9M
- VIATRIS INC$15.2M
Exited Positions
- CORCEPT THERAPEUTICS INC$27.2M
- LIVANOVA PLC$26.8M
- EMBECTA CORP$16.3M
- ABIVAX SA$15.1M
- HAEMONETICS CORP MASS$12.4M
Sio Capital Management, LLC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ANTERIS TECHNOLOGIES GLOBAL | AVR | 03675P102 | $54.6M | 9.04% | 5,545,984 | SH |
| 2 | CENCORA INC | COR | 03073E105 | $49.1M | 8.13% | 173,588 | SH |
| 3 | MAXIMUS INC | MMS | 577933104 | $38.5M | 6.36% | 715,267 | SH |
| 4 | ALLOGENE THERAPEUTICS INC | ALLO | 019770106 | $27.7M | 4.59% | 13,323,431 | SH |
| 5 | GLOBUS MED INC | GMED | 379577208 | $23.8M | 3.95% | 301,816 | SH |
| 6 | GSK PLC | GSK | 37733W204 | $22.9M | 3.79% | 436,700 | SH |
| 7 | TYRA BIOSCIENCES INC | TYRA | 90240B106 | $22.2M | 3.68% | 695,315 | SH |
| 8 | WAYSTAR HLDG CORP | WAY | 946784105 | $19.0M | 3.15% | 925,834 | SH |
| 9 | SELLAS LIFE SCIENCES GROUP I Put | SLS | 81642T209 | $18.2M | 3.01% | 1,230,700 | SH |
| 10 | IDEAYA BIOSCIENCES INC | IDYA | 45166A102 | $17.9M | 2.96% | 480,383 | SH |
| 11 | ORUKA THERAPEUTICS INC | ORKA | 687604108 | $16.9M | 2.79% | 177,118 | SH |
| 12 | THE CIGNA GROUP | CI | 125523100 | $15.9M | 2.63% | 57,750 | SH |
| 13 | SANOFI SA | SNY | 80105N105 | $15.5M | 2.57% | 364,200 | SH |
| 14 | ICON PUB LTD CO | ICLR | G4705A100 | $15.3M | 2.53% | 88,186 | SH |
| 15 | VIATRIS INC | VTRS | 92556V106 | $15.2M | 2.51% | 954,299 | SH |
| 16 | CROSS CTRY HEALTHCARE INC | CCRN | 227483104 | $14.5M | 2.40% | 1,098,393 | SH |
| 17 | RAPPORT THERAPEUTICS INC | RAPP | 75383L102 | $12.8M | 2.12% | 307,657 | SH |
| 18 | ABBOTT LABORATORIES | ABT | 002824100 | $11.7M | 1.93% | 128,656 | SH |
| 19 | CELCUITY INC | CELC | 15102K100 | $11.5M | 1.90% | 110,022 | SH |
| 20 | ZIMMER BIOMET HOLDINGS INC | ZBH | 98956P102 | $11.3M | 1.87% | 131,445 | SH |
| 21 | REGENERON PHARMACEUTICALS | REGN | 75886F107 | $11.2M | 1.86% | 18,000 | SH |
| 22 | BRISTOL-MYERS SQUIBB CO | BMY | 110122108 | $11.1M | 1.85% | 193,500 | SH |
| 23 | MEDTRONIC PLC | MDT | G5960L103 | $11.1M | 1.84% | 142,500 | SH |
| 24 | VIR BIOTECHNOLOGY INC | VIR | 92764N102 | $11.0M | 1.81% | 1,075,274 | SH |
| 25 | SENSEONICS HLDGS INC | SENS | 81727U303 | $9.0M | 1.50% | 1,592,692 | SH |
| 26 | EYEPOINT INC | EYPT | 30233G209 | $8.9M | 1.47% | 623,130 | SH |
| 27 | CYBIN INC | HELP | 23256X407 | $8.6M | 1.42% | 1,300,000 | SH |
| 28 | ANI PHARMACEUTICALS INC | ANIP | 00182C103 | $8.1M | 1.33% | 97,305 | SH |
| 29 | PROTARA THERAPEUTICS INC | TARA | 74365U107 | $7.3M | 1.21% | 1,921,872 | SH |
| 30 | RELMADA THERAPEUTICS INC | RLMD | 75955J402 | $6.9M | 1.15% | 1,003,562 | SH |
| 31 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $6.5M | 1.08% | 208,500 | SH |
| 32 | AQUESTIVE THERAPEUTICS INC | AQST | 03843E104 | $6.2M | 1.02% | 1,486,175 | SH |
| 33 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $5.8M | 0.96% | 59,254 | SH |
| 34 | SIONNA THERAPEUTICS INC | SION | 829401108 | $5.6M | 0.93% | 127,808 | SH |
| 35 | OCULAR THERAPEUTIX INC | OCUL | 67576A100 | $5.3M | 0.88% | 539,493 | SH |
| 36 | ZENAS BIOPHARMA INC | ZBIO | 98937L105 | $5.3M | 0.88% | 208,557 | SH |
| 37 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 10919W405 | $5.2M | 0.86% | 73,952 | SH |
| 38 | ONKURE THERAPEUTICS INC | OKUR | 68277Q105 | $4.9M | 0.81% | 1,078,965 | SH |
| 39 | SAVARA INC | SVRA | 805111101 | $3.8M | 0.63% | 617,675 | SH |
| 40 | PMV PHARMACEUTICALS INC | PMVP | 69353Y103 | $3.5M | 0.58% | 2,634,137 | SH |
| 41 | AVEANNA HEALTHCARE HLDGS INC | AVAH | 05356F105 | $3.2M | 0.52% | 369,036 | SH |
| 42 | OVID THERAPEUTICS INC | OVID | 690469101 | $2.7M | 0.45% | 1,005,334 | SH |
| 43 | IMMUNOME INC | IMNM | 45257U108 | $2.6M | 0.44% | 124,168 | SH |
| 44 | HIMS & HERS HEALTH INC Call | HIMS | 433000106 | $2.6M | 0.43% | 75,000 | SH |
| 45 | AN2 THERAPEUTICS INC | ANTX | 037326105 | $2.6M | 0.42% | 529,933 | SH |
| 46 | SERINA THERAPEUTICS INC | SER | 81751A108 | $1.9M | 0.32% | 1,000,000 | SH |
| 47 | ALIGOS THERAPEUTICS INC | ALGS | 01626L204 | $1.9M | 0.31% | 327,237 | SH |
| 48 | IBIO INC | IBIO | 451033708 | $1.6M | 0.26% | 904,268 | SH |
| 49 | XILIO THERAPEUTICS INC | XLO | 98422T209 | $1.5M | 0.24% | 152,464 | SH |
| 50 | ARTIVION INC | AORT | 228903100 | $1.1M | 0.18% | 48,481 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $604.3M | 59 | 0001214659-26-010311 |
| 2026-03-31 | 2026-05-14 | $697.3M | 76 | 0001214659-26-006200 |
| 2025-12-31 | 2026-02-17 | $635.7M | 68 | 0001214659-26-001854 |
| 2025-09-30 | 2025-11-13 | $395.2M | 51 | 0001214659-25-016415 |
2ND FLOOR
NEW YORK, NY 10016